Great summary by the newly released update to the AACE Evaluation and Treatment of Adults with Obesity 2025 Consensus Statement To view or add a comment, sign in Recommended paper~ Endocrine and Metabolic Mechanisms Linking Obesity to Type 2 Diabetes: Implications for Targeted Therapy by Salvatore Allocca et al
Understanding Tirzepatide and Semaglutide Tirzepatide (marketed under the name Mounjaro) and Semaglutide (marketed under names like Ozempic, Rybelsus, and Wegovy) are injectable medications used to improve blood sugar control in adults with type 2 diabetes
Disease areas Products Careers About us Patient help Healthcare professionals Media & Investors Contact us
First, we did not require patients to continuously take a GLP-1 RA for a pre-specified amount of time before discontinuation
The trend is evident that a higher concentration resulted in greater weight loss, and that semaglutide performed better compared to liraglutide, another GLP-1 receptor agonist, and placebo
One of the beneficial side effects of this novel treatment was a significant loss of body weight
